Violence Against Women in Patients With Alcohol Substance Addiction Training

Sponsor
Abant Izzet Baysal University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05595759
Collaborator
(none)
40
1
2
12
3.3

Study Details

Study Description

Brief Summary

This study was planned as a randomized controlled trial in order to determine the effect of creative drama training for alcohol-substance dependent male patients on their attitudes towards violence against women.

Condition or Disease Intervention/Treatment Phase
  • Other: Violence against women education supported by creative drama
  • Other: Routine service operation
N/A

Detailed Description

This study was planned as a randomized controlled trial in order to determine the effect of creative drama training for alcohol-substance dependent male patients on their attitudes towards violence against women.

The study was planned to be fully experimental. The participants to be included in the study will be selected from men who are followed up with a diagnosis of addiction in a mental health hospital. In the experimental group, male patients will be given violence against women training supported by creative drama five days a day. It will be used as an improved scale-measuring tool for women before and after the training. In the control group, the trainings applied in the service operation will be applied. It will be used as an improved scale-measuring tool for women before and after the training.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
randomized controlled trialrandomized controlled trial
Masking:
Single (Participant)
Masking Description:
In this study, the names of the patients hospitalized in the two wards will be sorted and numbered in alphabetical order. After the numbering process, the patients will be selected to the experimental and control group by using the "https://www.randomizer.org/" site by an independent specialist. In this study, the names of the patients hospitalized in the two wards will be sorted and numbered in alphabetical order. After the numbering process, the patients will be divided into an experimental and control group using the "https://www.randomizer.org/" site by an independent specialist.
Primary Purpose:
Other
Official Title:
The Effect of Creative Drama Training for Alcohol-Substance Addicted Male Patients on Attitudes Towards Violence Against Women: A Randomized Controlled Study
Actual Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Feb 1, 2023
Anticipated Study Completion Date :
Sep 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Male patients with a diagnosis of alcohol and substance abuse

Male patients with a diagnosis of alcohol and substance abuse

Other: Violence against women education supported by creative drama
Violence against women supported by creative drama training will be applied to male patients diagnosed with addiction every day for 5 days.

Other: Routine service operation

Male patients with a diagnosis of alcohol and substance abuse

Other: Routine service operation
No additional training will be applied to the control group and SAMBA trainings in the service operation will be applied.

Outcome Measures

Primary Outcome Measures

  1. Pretest final test scores on violence against women [10 day]

    Developed by Yalçın Kanbay in 2016, it is a 5-piece Likert type measurement tool consisting of two factors and 30 items. The scale has two sub-dimensions: "attitudes towards the body" and "attitudes towards identity". The total score of the scale is obtained by collecting the scores from two factors. On the scale, there are five answer options. In the scoring of the scale, each question is scored between 1-5. The high scores indicate that they are against violence against women, while the low scores indicate that they are not against violence against women. From the general scale, the lowest score is 30 and the highest score is 150. Kanbay found the Cronbach α value of the scale 0.86 for the overall scale. It is stated that the scale can be applied to individuals with at least primary school graduation and age between 15-65 years of age.

  2. Pretest final test scores [10 days]

    Developed by Yalçın Kanbay in 2016, it is a 5-piece Likert type measurement tool consisting of two factors and 30 items. The scale has two sub-dimensions: "attitudes towards the body" and "attitudes towards identity". The total score of the scale is obtained by collecting the scores from two factors. On the scale, there are five answer options. In the scoring of the scale, each question is scored between 1-5. The high scores indicate that they are against violence against women, while the low scores indicate that they are not against violence against women. From the general scale, the lowest score is 30 and the highest score is 150. Kanbay found the Cronbach α value of the scale 0.86 for the overall scale. It is stated that the scale can be applied to individuals with at least primary school graduation and age between 15-65 years of age.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Literate,

  • Male inclusion,

  • Have reached the age of 18,

  • do not have an acute psychotic illness,

  • Patients without symptoms of delirium tremens or intense withdrawal made up the study group of this study.

Exclusion Criteria:
  • Illiterate,Woman,

  • Have an acute psychotic illness,

  • Delirium tremens or those with symptoms of intense withdrawal,

  • Patients who did not agree to participate in the study were not included in this study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mental Health and Diseases Hospital Bolu Turkey 14100

Sponsors and Collaborators

  • Abant Izzet Baysal University

Investigators

  • Principal Investigator: hümeyra Hançer tok, msc, Abant Izzet Baysal University

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
HUMEYRA HANCER TOK, Head of Otolaryngology, Abant Izzet Baysal University
ClinicalTrials.gov Identifier:
NCT05595759
Other Study ID Numbers:
  • AİBÜ-HEM-HHT-01
First Posted:
Oct 27, 2022
Last Update Posted:
Oct 27, 2022
Last Verified:
Oct 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by HUMEYRA HANCER TOK, Head of Otolaryngology, Abant Izzet Baysal University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 27, 2022